These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29912151)

  • 1. Identification of a 3-Alkylpyridinium Compound from the Red Sea Sponge
    O'Rourke A; Kremb S; Duggan BM; Sioud S; Kharbatia N; Raji M; Emwas AH; Gerwick WH; Voolstra CR
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29912151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
    Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold.
    Samanta S; Lim TL; Lam Y
    ChemMedChem; 2013 Jun; 8(6):994-1001. PubMed ID: 23619931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease.
    Schöne T; Grimm LL; Sakai N; Zhang L; Hilgenfeld R; Peters T
    Antiviral Res; 2017 Oct; 146():174-183. PubMed ID: 28927677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
    Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA
    Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor.
    Martinez AA; Espinosa BA; Adamek RN; Thomas BA; Chau J; Gonzalez E; Keppetipola N; Salzameda NT
    Eur J Med Chem; 2018 Sep; 157():1202-1213. PubMed ID: 30193218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C Virus NS3 Protease and Helicase Inhibitors from Red Sea Sponge (
    Shady NH; Khattab AR; Ahmed S; Liu M; Quinn RJ; Fouad MA; Kamel MS; Muhsinah AB; Krischke M; Mueller MJ; Abdelmohsen UR
    Int J Nanomedicine; 2020; 15():3377-3389. PubMed ID: 32494136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A FRET-based assay for the discovery of West Nile Virus NS2B-NS3 protease inhibitors.
    Adamek RN; Maniquis RV; Khakoo S; Bridges MD; Salzameda NT
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4848-50. PubMed ID: 23886689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. West Nile Virus NS2B/NS3 protease as an antiviral target.
    Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
    Curr Med Chem; 2008; 15(27):2771-84. PubMed ID: 18991636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Amphimedon sp.
    Fujimoto Y; Salam KA; Furuta A; Matsuda Y; Fujita O; Tani H; Ikeda M; Kato N; Sakamoto N; Maekawa S; Enomoto N; de Voogd NJ; Nakakoshi M; Tsubuki M; Sekiguchi Y; Tsuneda S; Akimitsu N; Noda N; Yamashita A; Tanaka J; Moriishi K
    PLoS One; 2012; 7(11):e48685. PubMed ID: 23144928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 1,3,4,5-tetrasubstituted 1H-pyrrol-2(5H)-one scaffold.
    Gao Y; Samanta S; Cui T; Lam Y
    ChemMedChem; 2013 Sep; 8(9):1554-60. PubMed ID: 23868614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking.
    Ekonomiuk D; Su XC; Ozawa K; Bodenreider C; Lim SP; Yin Z; Keller TH; Beer D; Patel V; Otting G; Caflisch A; Huang D
    PLoS Negl Trop Dis; 2009; 3(1):e356. PubMed ID: 19159012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus.
    Johnston PA; Phillips J; Shun TY; Shinde S; Lazo JS; Huryn DM; Myers MC; Ratnikov BI; Smith JW; Su Y; Dahl R; Cosford ND; Shiryaev SA; Strongin AY
    Assay Drug Dev Technol; 2007 Dec; 5(6):737-50. PubMed ID: 18181690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
    Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
    Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery, synthesis, and in vitro evaluation of West Nile virus protease inhibitors based on the 9,10-dihydro-3H,4aH-1,3,9,10a-tetraazaphenanthren-4-one scaffold.
    Samanta S; Cui T; Lam Y
    ChemMedChem; 2012 Jul; 7(7):1210-6. PubMed ID: 22550001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miniature bovine pancreatic trypsin inhibitors (m-BPTIs) of the West Nile virus NS2B-NS3 protease.
    Ang MJ; Lim HA; Poulsen A; Wee JL; Ng FM; Joy J; Hill J; Chia CS
    J Enzyme Inhib Med Chem; 2016; 31(sup2):194-200. PubMed ID: 27241372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphonate inhibitors of West Nile virus NS2B/NS3 protease.
    Skoreński M; Milewska A; Pyrć K; Sieńczyk M; Oleksyszyn J
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):8-14. PubMed ID: 30362835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
    Stoermer MJ; Chappell KJ; Liebscher S; Jensen CM; Gan CH; Gupta PK; Xu WJ; Young PR; Fairlie DP
    J Med Chem; 2008 Sep; 51(18):5714-21. PubMed ID: 18729351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel West Nile Virus protease inhibitor based on isobenzonafuranone and triazolic derivatives of eugenol and indan-1,3-dione scaffolds.
    de Oliveira AS; Gazolla PAR; Oliveira AFCDS; Pereira WL; de S Viol LC; Maia AFDS; Santos EG; da Silva ÍEP; Mendes TAO; da Silva AM; Dias RS; da Silva CC; Polêto MD; Teixeira RR; de Paula SO
    PLoS One; 2019; 14(9):e0223017. PubMed ID: 31557229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two antiviral compounds from the plant Stylogne cauliflora as inhibitors of HCV NS3 protease.
    Hegde VR; Pu H; Patel M; Das PR; Butkiewicz N; Arreaza G; Gullo VP; Chan TM
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2925-8. PubMed ID: 14611859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.